ZYDELIG Film-coated tablet Ref.[9140] Active ingredients: Idelalisib

Source: European Medicines Agency (EU)  Revision Year: 2020  Publisher: Gilead Sciences Ireland UC, Carrigtohill, County Cork, T45 DP77, Ireland

Product name and form

Zydelig 100 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet.

Orange, oval-shaped, film-coated tablet of dimensions 9.7 mm by 6.0 mm, debossed on one side with “GSI” and “100” on the other side.

Qualitative and quantitative composition

Each film-coated tablet contains 100 mg of idelalisib.

Excipient with known effect: Each tablet contains 0.1 mg sunset yellow FCF (E110) (see section 4.4).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Idelalisib

Idelalisib inhibits phosphatidylinositol 3-kinase p110δ (PI3Kδ), which is hyperactive in B-cell malignancies and is central to multiple signalling pathways that drive proliferation, survival, homing, and retention of malignant cells in lymphoid tissues and bone marrow. Idelalisib induces apoptosis and inhibits proliferation in cell lines derived from malignant B-cells and in primary tumour cells.

List of Excipients

Tablet core:

Microcrystalline cellulose
Hydroxypropyl cellulose (E463)
Croscarmellose sodium
Sodium starch glycolate
Magnesium stearate

Film-coating:

Polyvinyl alcohol (E1203)
Macrogol 3350 (E1521)
Titanium dioxide (E171)
Talc (E553B)
Sunset yellow FCF (E110)

Pack sizes and marketing

High density polyethylene (HDPE) bottle, capped with a polypropylene child-resistant closure, containing 60 film-coated tablets and a polyester coil.

Each carton contains 1 bottle.

Marketing authorization holder

Gilead Sciences Ireland UC, Carrigtohill, County Cork, T45 DP77, Ireland

Marketing authorization dates and numbers

EU/1/14/938/001

Date of first authorisation: 18 September 2014
Date of latest renewal: 30 April 2019

Drugs

Drug Countries
ZYDELIG Austria, Australia, Canada, Cyprus, Estonia, Spain, France, Ireland, Lithuania, Netherlands, New Zealand, Poland, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.